Wearable device aims to spot trouble before It's too late for ICU survivors

NCT ID NCT06815718

First seen Feb 27, 2026 · Last updated Jun 23, 2026 · Updated 12 times

Summary

This study tested a wearable device called viQtor on 180 adults who had just left the ICU. The device continuously tracks heart rate, breathing rate, oxygen levels, and activity. The goal was to create a new early warning score that could alert nurses sooner if a patient's condition worsens, compared to standard checks. The study is now complete and focused on developing and validating this scoring system.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MONITORING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Erasmus MC

    Rotterdam, South Holland, 3015GD, Netherlands

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

viQtor continuous monitoring device

What this could lead to

If successful, this could lead to a better early warning system for patients leaving the ICU, potentially reducing emergency interventions and readmissions.

What could go wrong

This is a small, completed observational study focused on developing a scoring system, not testing a treatment. The device may not improve outcomes in real-world use.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.